Amphastar Pharmaceuticals, Inc. Capitalized Computer Software, Amortization
Amphastar Pharmaceuticals, Inc. (AMPH) reported Capitalized Computer Software, Amortization of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:CapitalizedComputerSoftwareAmortization1 · last filed 2026-08-06
- Amphastar Pharmaceuticals, Inc. capitalized computer software, amortization for the quarter ending 2026-06-30 was $0.00.
- Amphastar Pharmaceuticals, Inc. capitalized computer software, amortization for the quarter ending 2026-03-31 was $0.00.
- Amphastar Pharmaceuticals, Inc. capitalized computer software, amortization for the quarter ending 2025-09-30 was $0.00.
- Amphastar Pharmaceuticals, Inc. capitalized computer software, amortization for the quarter ending 2025-06-30 was $0.00.
| Period end | Capitalized Computer Software, Amortization 3 month | Capitalized Computer Software, Amortization 6 month | Capitalized Computer Software, Amortization 9 month | Capitalized Computer Software, Amortization 24 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | ||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | $0.00 10-K · filed 2026-02-26 | |||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2026-08-06 | $0.00 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | ||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-07 | |||
| 2024-09-30 | $0.00 10-Q · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-07 | $0.00 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |